Skip to content

Early Breast Feeding and Glucose Levels in High Risk Newborns

Does Early Breast Feeding Prevents Neonatal Hypoglycemia in High Risk Newborns

Status
UNKNOWN
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT00332449
Enrollment
100
Registered
2006-06-01
Start date
2007-06-30
Completion date
2008-12-31
Last updated
2008-04-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Neonatal Hypoglycemia

Keywords

early breast feeding, hypoglycemia, newborn

Brief summary

Early breast feeding has shown to be important to mother-infant bonding and is associated with longer duration of breast feeding. However, little data is available regarding its contribution to glucose levels in the newborn infants. Newborns that are at risk to develop hypoglycemia may benefit from early breast feeding if this appears to prevent post-partum hypoglycemia.

Detailed description

Mothers will be encouraged to breast feed early after delivery (at the delivery room). Data of high risk babies for developing post partum hypoglycemia (Infants of diabetic mothers, infants of hypertensive mothers, infants with birth weight more than 4 Kg or less than 2.5 Kg and infants with meconium stained amniotic fluid)will be recorded including maternal breast feeding times and quality of feeding. Glucose levels shall be routinely monitored and recorded at the neonatal department. A comparison of all data will be made between those newborns that breast feed after labor and those who were not.

Interventions

None listed

Sponsors

Sheba Medical Center
Lead SponsorOTHER_GOV

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
1 Days to 1 Days
Healthy volunteers
No

Inclusion criteria

* Newborns to diabetic mothers * Newborns to hypertensive mothers * Newborns with birth weight greater than 4 Kg or less than 2.5 Kg * Newborns with meconium stained amniotic fluid

Exclusion criteria

* Newborns with major congenital malformation * Preterm babies * Newborns with post-birth distress

Design outcomes

Primary

MeasureTime frame
normal neonatal glucose levels2 days

Secondary

MeasureTime frame
Hypoglycemia prevention2 days

Countries

Israel

Contacts

Primary ContactAyala Maayan, MD
ayala.maayan@sheba.health.gov.il972-3-530-2043

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026